Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 09-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -3,847 | -23,360 | -17,445 | -18,840 |
| Depreciation Amortization | 392 | 1,500 | 965 | 1,110 |
| Accounts receivable | 816 | N/A | -693 | N/A |
| Accounts payable and accrued liabilities | -1,356 | N/A | 320 | N/A |
| Other Working Capital | -2,454 | 80 | -1,093 | -2,960 |
| Other Operating Activity | -338 | 970 | -63 | -2,800 |
| Operating Cash Flow | $-6,788 | $-20,810 | $-18,009 | $-23,490 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -12 | -1,010 | -736 | -1,340 |
| Investing Cash Flow | $-12 | $-1,010 | $-736 | $-1,340 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 13,330 | N/A | N/A | N/A |
| Common Stock Issued | 0 | N/A | 2 | N/A |
| Other Financing Activity | 0 | 17,600 | 16,132 | 25,430 |
| Financing Cash Flow | $13,330 | $17,600 | $16,133 | $25,430 |
| Beginning Cash Position | 1,022 | 5,240 | 5,250 | 4,660 |
| End Cash Position | 7,553 | 1,020 | 2,634 | 5,240 |
| Net Cash Flow | $6,531 | $-4,220 | $-2,612 | $580 |
| Free Cash Flow | ||||
| Operating Cash Flow | -6,788 | -20,810 | -18,009 | -23,490 |
| Capital Expenditure | -12 | N/A | -736 | N/A |
| Free Cash Flow | -6,799 | -20,810 | -18,745 | -23,490 |